利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

34 条记录 (耗时 0.066 秒)

    Heterocyclic compounds and uses as anticancer agents
    2.
    发明授权
    Heterocyclic compounds and uses as anticancer agents 有权
    杂环化合物和用作抗癌剂

    公开(公告)号：US08252822B2

    公开(公告)日：2012-08-28

    申请号：US12175154

    申请日：2008-07-17

    申请人： Haoyun An ,  Biao Xi ,  Yama Abassi ,  Xiaobo Wang ,  Xiao Xu

    发明人： Haoyun An ,  Biao Xi ,  Yama Abassi ,  Xiaobo Wang ,  Xiao Xu

    IPC分类号： A61K31/429 ,  C07D513/04

    CPC分类号： C07D487/04 ,  C07D498/04 ,  C07D513/04

    摘要： Novel compounds having a fused bicyclic heteroaromatic ring system substituted with a heteroaryl five-membered ring are disclosed. The compounds inhibit growth of a variety of types of cancer cells, and are thus useful for treating cancer. Efficacy of these compounds is demonstrated with a system for monitoring cell growth/migration, which shows they are potent inhibitors of growth and/or migration of cancer cells. In addition, compounds of the invention were shown to stop growth of tumors in vivo, and to reduce the size of tumors in vivo. Compositions comprising these compounds, and methods to use these compounds and compositions for treatment of cancers, are disclosed.

    摘要翻译： 公开了具有被杂芳基五元环取代的稠合双环杂芳环系的新型化合物。 这些化合物抑制多种类型的癌细胞的生长，因此可用于治疗癌症。 通过用于监测细胞生长/迁移的系统来证明这些化合物的功效，这表明它们是癌细胞的生长和/或迁移的有效抑制剂。 此外，本发明的化合物被证明可以在体内停止肿瘤生长，并减少体内肿瘤的大小。 公开了包含这些化合物的组合物，以及使用这些化合物和用于治疗癌症的组合物的方法。

    HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS
    6.
    发明申请
    HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS 有权
    杂环化合物和作为反应剂的用途

    公开(公告)号：US20090048271A1

    公开(公告)日：2009-02-19

    申请号：US12175154

    申请日：2008-07-17

    申请人： Haoyun An ,  Biao Xi ,  Yama Abassi ,  Xiaobo Wang ,  Xiao Xu

    发明人： Haoyun An ,  Biao Xi ,  Yama Abassi ,  Xiaobo Wang ,  Xiao Xu

    IPC分类号： A61K31/519 ,  A61P35/00 ,  C07D487/04 ,  A61K31/429 ,  C07D513/04

    CPC分类号： C07D487/04 ,  C07D498/04 ,  C07D513/04

    摘要： Novel compounds having a fused bicyclic heteroaromatic ring system substituted with a heteroaryl five-membered ring are disclosed. The compounds inhibit growth of a variety of types of cancer cells, and are thus useful for treating cancer. Efficacy of these compounds is demonstrated with a system for monitoring cell growth/migration, which shows they are potent inhibitors of growth and/or migration of cancer cells. In addition, compounds of the invention were shown to stop growth of tumors in vivo, and to reduce the size of tumors in vivo. Compositions comprising these compounds, and methods to use these compounds and compositions for treatment of cancers, are disclosed.

    摘要翻译： 公开了具有被杂芳基五元环取代的稠合双环杂芳环系的新型化合物。 这些化合物抑制多种类型的癌细胞的生长，因此可用于治疗癌症。 通过用于监测细胞生长/迁移的系统来证明这些化合物的功效，这表明它们是癌细胞的生长和/或迁移的有效抑制剂。 此外，本发明的化合物被证明可以在体内停止肿瘤生长，并减少体内肿瘤的大小。 公开了包含这些化合物的组合物，以及使用这些化合物和用于治疗癌症的组合物的方法。

    PYRIMIDINE NUCLEOSIDE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF FOR PREPARING ANTI-TUMOR AND ANTI-VIRUS MEDICAMENTS
    7.
    发明申请
    PYRIMIDINE NUCLEOSIDE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF FOR PREPARING ANTI-TUMOR AND ANTI-VIRUS MEDICAMENTS 有权
    吡咯烷酮核苷衍生物，合成方法及其制备抗肿瘤药物和抗病毒药物的用途

    公开(公告)号：US20130303747A1

    公开(公告)日：2013-11-14

    申请号：US13820993

    申请日：2011-09-02

    申请人： Junbiao Chang ,  Haoyun An ,  Xuejun Yu ,  Xiaohe Guo

    发明人： Junbiao Chang ,  Haoyun An ,  Xuejun Yu ,  Xiaohe Guo

    IPC分类号： C07H19/06

    CPC分类号： C07H19/06 ,  C07H19/14

    摘要： The present invention relates to the field of pharmacochemistry. Disclosed are fluorinated and azido-substituted pyrimidine nucleoside derivatives, and preparation methods and uses thereof. The structural formula is as shown (I). These compounds can be used for preparing medicaments for treating diseases such as tumors and viral infections, and can be used separately or in combination with other medicaments. The compounds also have effective activity against diseases such as tumors and viral infections, while having few side effects, and thus have potential application value.

    摘要翻译： 本发明涉及药物化学领域。 公开了氟化和叠氮基取代的嘧啶核苷衍生物及其制备方法和用途。 结构式如图（I）所示。 这些化合物可用于制备用于治疗诸如肿瘤和病毒感染的疾病的药物，并且可以单独使用或与其它药物组合使用。 该化合物还具有抗肿瘤和病毒感染等疾病的有效活性，同时副作用少，具有潜在的应用价值。

    Tetrahydrocannabinoid antigens and method of use
    8.
    发明申请
    Tetrahydrocannabinoid antigens and method of use 审中-公开
    四氢大麻素抗原及其使用方法

    公开(公告)号：US20060051824A1

    公开(公告)日：2006-03-09

    申请号：US11048648

    申请日：2005-01-31

    申请人： Haoyun An ,  Junjie Xu ,  Jose Alberto Macall

    发明人： Haoyun An ,  Junjie Xu ,  Jose Alberto Macall

    IPC分类号： G01N33/537

    CPC分类号： G01N33/948 ,  A61K47/646 ,  C07D311/80 ,  C07K16/44 ,  G01N33/6854

    摘要： The present invention is directed to Δ8-THC and Δ9-THC compounds useful for the covalent attachment to immunogenic molecules to form antigens for the preparation of specific binding molecules to Δ9-Tetrahydrocannabinol, Δ9-Tetrahydrocannabinoids, Δ8-Tetrahydrocannabinol, and Δ8-Tetrahydrocannabinoids, and their derivatives and metabolites. The present invention is directed to the compounds, their method of preparation, cell lines producing the specific binding molecules, methods of using the antigens to produce the specific binding molecules, and test devices containing the antigens, haptens, or specific binding molecules of the invention.

    摘要翻译： 本发明涉及可用于共价连接到免疫原性分子以形成用于制备特异性结合分子的抗原的Delta -THTH -THC和Δ-9 -THC化合物 四氢大麻酚，三氢大麻酚，四氢大麻素，三角洲四氢大麻酚和三角洲四氢大麻素，以及它们 衍生物和代谢物。 本发明涉及化合物，其制备方法，产生特异性结合分子的细胞系，使用抗原产生特异性结合分子的方法以及含有本发明抗原，半抗原或特异性结合分子的测试装置 。

    Compounds having a plurality of nitrogenous substitutents
    9.
    发明授权
    Compounds having a plurality of nitrogenous substitutents 失效
    具有多个含氮取代基的化合物

    公开(公告)号：US06329523B1

    公开(公告)日：2001-12-11

    申请号：US09230773

    申请日：1999-03-10

    申请人： Phillip Dan Cook ,  Haoyun An

    发明人： Phillip Dan Cook ,  Haoyun An

    IPC分类号： C07D24142

    CPC分类号： C07D213/20 ,  C12Q1/18 ,  C40B40/00 ,  G01N33/573 ,  G01N33/68 ,  G01N33/6872

    摘要： Novel compounds having the formula: wherein the constituent variables are defined herein. The compounds are constructed to include a central aromatic, aliphatic, or heterocyclic ring system. Attached to the central ring system are two linear groups having nitrogenous moieties that are derivatized with chemical functional groups. The ring system can include further nitrogenous moieties, either as ring atoms or on pendant groups attached to the ring, that may also be derivatized with chemical functional groups. The totality of the chemical functional groups imparts certain conformational and other properties to the these compounds. In accordance with certain embodiments of the invention, libraries of such compounds are prepared utilizing permutations and combinations of the chemical functional groups and the nitrogenous moieties to build complexity into the libraries.

    摘要翻译： 具有下式的新型化合物：其中组分变量在本文中定义。 该化合物构建成包括中心芳族，脂族或杂环环系。 连接到中心环系统是具有用化学官能团衍生的含氮部分的两个线性基团。 环系统可以包括作为环原子的另外的含氮部分或连接到环的侧基，其也可以被化学官能团衍生化。 化学官能团的整体赋予这些化合物某些构象和其他性质。 根据本发明的某些实施方案，利用化学官能团和含氮部分的置换和组合来制备这些化合物的文库，以构建文库的复杂性。

    Nitrogenous macrocyclic compounds
    10.
    发明授权
    Nitrogenous macrocyclic compounds 失效
    含氮大环化合物

    公开(公告)号：US6107482A

    公开(公告)日：2000-08-22

    申请号：US913664

    申请日：1997-09-19

    申请人： Phillip Dan Cook ,  Haoyun An ,  Charles J. Guinosso ,  Pei-Pei Kung ,  Allister S. Fraser

    发明人： Phillip Dan Cook ,  Haoyun An ,  Charles J. Guinosso ,  Pei-Pei Kung ,  Allister S. Fraser

    IPC分类号： G01N33/15 ,  A61K31/33 ,  A61K31/395 ,  A61K31/435 ,  A61K31/53 ,  A61P29/00 ,  A61P31/04 ,  A61P43/00 ,  C07B61/00 ,  C07D255/02 ,  C07D273/00 ,  C07D471/08 ,  C07D471/18 ,  C07D498/08 ,  C07D515/08 ,  C07D521/00

    CPC分类号： C07D471/08 ,  C07D515/08 ,  B01J2219/0072

    摘要： Novel macrocyclic compounds are constructed to include large cyclic structures that are interrupted by at least one ring system. Each interrupting ring system includes two bridgehead atoms. Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical functional groups. The ring systems can include further nitrogenous moieties, either as ring atoms or on pendant groups attached to the ring. These can also be derivatized with chemical functional groups. The totality of the chemical functional groups imparts certain conformational and other properties to the macrocyclic compounds. In accordance with certain embodiments of the invention, libraries of such macrocyclic compounds are prepared utilizing permutations and combinations of the chemical functional groups and the nitrogenous moieties to build complexity into the library.

    摘要翻译： PCT No.PCT / US96 / 04215 Sec。 371日期：1997年9月19日 102（e）1997年9月19日PCT PCT 1996年3月27日PCT公布。 第WO96 / 30377号公报 日期1996年10月3日新的大环化合物被构建成包括被至少一个环系统中断的大环状结构。 每个中断环系统包括两个桥头原子。 桥头原子键合到一个或多个互连一个或多个环系统的桥，从而形成大的环状结构。 位于每个桥中的是具有化学官能团衍生化的两个或多个含氮部分。 环系统可以包括作为环原子的另外的含氮部分或连接到环上的侧基上。 这些也可以用化学官能团衍生化。 化学官能团的总体对大环化合物赋予某些构象和其他性质。 根据本发明的某些实施方案，利用化学官能团和含氮部分的置换和组合来制备这种大环化合物的文库，从而构建文库的复杂性。